AVVH Quote, Financials, Valuation and Earnings

Federal Home Loan Mortgage has a net margin of -- compared to AVVAA World Health Care Products's net margin of 53.19%. AVVAA World Health Care Products's return on equity of -- beat Federal Home Loan Mortgage's return on equity of 22.88%.

AVVAA World Health Care Products has a consensus price target of --, signalling downside risk potential of --. On the other hand Federal Home Loan Mortgage has an analysts' consensus of -- which suggests that it could fall by -38%. Given that Federal Home Loan Mortgage has higher upside potential than AVVAA World Health Care Products, analysts believe Federal Home Loan Mortgage is more attractive than AVVAA World Health Care Products.

AVVAA World Health Care Products has a beta of -1.345, which suggesting that the stock is 234.538% less volatile than S&P 500. In comparison Federal Home Loan Mortgage has a beta of 2.080, suggesting its more volatile than the S&P 500 by 108.047%.

AVVAA World Health Care Products has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Federal Home Loan Mortgage offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AVVAA World Health Care Products pays -- of its earnings as a dividend. Federal Home Loan Mortgage pays out -- of its earnings as a dividend.

AVVAA World Health Care Products quarterly revenues are --, which are smaller than Federal Home Loan Mortgage quarterly revenues of $5.8B. AVVAA World Health Care Products's net income of -- is lower than Federal Home Loan Mortgage's net income of $3.1B. Notably, AVVAA World Health Care Products's price-to-earnings ratio is -- while Federal Home Loan Mortgage's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AVVAA World Health Care Products is -- versus 0.37x for Federal Home Loan Mortgage. Usually stocks with elevated PS ratios are considered overvalued.

Horizon Technology Finance has a net margin of -- compared to AVVAA World Health Care Products's net margin of 80.24%. AVVAA World Health Care Products's return on equity of -- beat Horizon Technology Finance's return on equity of -1.15%.

AVVAA World Health Care Products has a consensus price target of --, signalling downside risk potential of --. On the other hand Horizon Technology Finance has an analysts' consensus of -- which suggests that it could grow by 9.86%. Given that Horizon Technology Finance has higher upside potential than AVVAA World Health Care Products, analysts believe Horizon Technology Finance is more attractive than AVVAA World Health Care Products.

AVVAA World Health Care Products has a beta of -1.345, which suggesting that the stock is 234.538% less volatile than S&P 500. In comparison Horizon Technology Finance has a beta of 1.222, suggesting its more volatile than the S&P 500 by 22.177%.

AVVAA World Health Care Products has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Horizon Technology Finance offers a yield of 14.77% to investors and pays a quarterly dividend of $0.11 per share. AVVAA World Health Care Products pays -- of its earnings as a dividend. Horizon Technology Finance pays out -235.81% of its earnings as a dividend.

AVVAA World Health Care Products quarterly revenues are --, which are smaller than Horizon Technology Finance quarterly revenues of $9.1M. AVVAA World Health Care Products's net income of -- is lower than Horizon Technology Finance's net income of $7.3M. Notably, AVVAA World Health Care Products's price-to-earnings ratio is -- while Horizon Technology Finance's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AVVAA World Health Care Products is -- versus 73.71x for Horizon Technology Finance. Usually stocks with elevated PS ratios are considered overvalued.

IF Bancorp has a net margin of -- compared to AVVAA World Health Care Products's net margin of 10.16%. AVVAA World Health Care Products's return on equity of -- beat IF Bancorp's return on equity of 2.68%.

AVVAA World Health Care Products has a consensus price target of --, signalling downside risk potential of --. On the other hand IF Bancorp has an analysts' consensus of -- which suggests that it could fall by --. Given that AVVAA World Health Care Products has higher upside potential than IF Bancorp, analysts believe AVVAA World Health Care Products is more attractive than IF Bancorp.

AVVAA World Health Care Products has a beta of -1.345, which suggesting that the stock is 234.538% less volatile than S&P 500. In comparison IF Bancorp has a beta of 0.507, suggesting its less volatile than the S&P 500 by 49.277%.

AVVAA World Health Care Products has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IF Bancorp offers a yield of 1.74% to investors and pays a quarterly dividend of $0.20 per share. AVVAA World Health Care Products pays -- of its earnings as a dividend. IF Bancorp pays out 71.45% of its earnings as a dividend. IF Bancorp's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

AVVAA World Health Care Products quarterly revenues are --, which are smaller than IF Bancorp quarterly revenues of $6.2M. AVVAA World Health Care Products's net income of -- is lower than IF Bancorp's net income of $633K. Notably, AVVAA World Health Care Products's price-to-earnings ratio is -- while IF Bancorp's PE ratio is 37.70x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AVVAA World Health Care Products is -- versus 3.19x for IF Bancorp. Usually stocks with elevated PS ratios are considered overvalued.

Mag Mile Capital has a net margin of -- compared to AVVAA World Health Care Products's net margin of -176.99%. AVVAA World Health Care Products's return on equity of -- beat Mag Mile Capital's return on equity of -118.44%.

AVVAA World Health Care Products has a consensus price target of --, signalling downside risk potential of --. On the other hand Mag Mile Capital has an analysts' consensus of -- which suggests that it could fall by --. Given that AVVAA World Health Care Products has higher upside potential than Mag Mile Capital, analysts believe AVVAA World Health Care Products is more attractive than Mag Mile Capital.

AVVAA World Health Care Products has a beta of -1.345, which suggesting that the stock is 234.538% less volatile than S&P 500. In comparison Mag Mile Capital has a beta of 2.887, suggesting its more volatile than the S&P 500 by 188.653%.

AVVAA World Health Care Products has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Mag Mile Capital offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AVVAA World Health Care Products pays -- of its earnings as a dividend. Mag Mile Capital pays out -- of its earnings as a dividend.

AVVAA World Health Care Products quarterly revenues are --, which are smaller than Mag Mile Capital quarterly revenues of $254.6K. AVVAA World Health Care Products's net income of -- is lower than Mag Mile Capital's net income of -$450.5K. Notably, AVVAA World Health Care Products's price-to-earnings ratio is -- while Mag Mile Capital's PE ratio is 24,477.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AVVAA World Health Care Products is -- versus 2,359.35x for Mag Mile Capital. Usually stocks with elevated PS ratios are considered overvalued.